Ritter Daniher Financial Advisory’s Medifast MED Stock Holding History

Ritter Daniher Financial Advisory’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$11	–	620
2026 Q1	$11	Buy	+1	New	+$11	﹤0.01%	590

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ritter Daniher Financial Advisory's MED Position: Q2 2026 in Review

Ritter Daniher Financial Advisory sold out of Medifast (MED) in Q2 2026, closing a stake of 1 share — an estimated $11 sold.

Ritter Daniher Financial Advisory first reported a position in MED in Q1 2026 and held it in 1 quarter. The position peaked at $11 in Q1 2026. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Ritter Daniher Financial Advisory reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
Ritter Daniher Financial Advisory sold 1 Medifast share in Q2 2026, an estimated $11.
Ritter Daniher Financial Advisory first reported a position in Medifast in Q1 2026 and held it in 1 quarter.
Ritter Daniher Financial Advisory's Medifast position peaked at $11 in Q1 2026.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.